Detalhe da pesquisa
1.
Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.
Blood
; 139(15): 2347-2354, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108372
2.
MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML.
Blood
; 132(14): 1526-1534, 2018 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30049810
3.
Molecular Minimal Residual Disease Detection in Acute Myeloid Leukemia.
Cancers (Basel)
; 13(21)2021 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771594
4.
RNA sequencing reveals a unique fusion of the lysine (K)-specific methyltransferase 2A and smooth muscle myosin heavy chain 11 in myelodysplastic syndrome and acute myeloid leukemia.
Haematologica
; 100(1): e1-3, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25552680
5.
PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse.
Leukemia
; 35(9): 2693-2697, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33589749
6.
Archived bone marrow smears are an excellent source for NGS-based mutation detection in acute myeloid leukemia.
Leukemia
; 34(8): 2220-2224, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32060404